Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
PER2 is a member of the Period family of genes and is expressed in a circadian pattern in the suprachiasmatic nucleus, the primary circadian pacemaker in the mammalian brain. Zusätzlich bieten wir Ihnen PER2 Kits (6) und PER2 Proteine (4) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 109 products:
Mouse (Murine) Monoclonal PER2 Primary Antibody für IF, WB - ABIN968388
Albrecht, Sun, Eichele, Lee: A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. in Cell 1998
Show all 2 Pubmed References
Human Monoclonal PER2 Primary Antibody für IF, IHC (p) - ABIN563850
Zhao, Zeng, Yang, Jin, Qiu, Hu, Han, Liu, Liao, Xu, Zou: Prognostic relevance of Period1 (Per1) and Period2 (Per2) expression in human gastric cancer. in International journal of clinical and experimental pathology 2014
Show all 2 Pubmed References
Human Polyclonal PER2 Primary Antibody für ICC, IF - ABIN151056
Lee, Jang, Francey, Sehgal, Hogenesch: KPNB1 mediates PER/CRY nuclear translocation and circadian clock function. in eLife 2015
The results suggest that the PER2 gene may be a risk factor for RA, and expression of the PER2 protein may be affected by inflammation. Therefore, PER2 may contribute to the pathogenesis of RA.
p53 (zeige TP53 Antikörper)'s nuclear shuttling was significantly favored by ectopic expression of Per2 and reduced because of Per2 down-regulation.
In human oral squamous cell carcinoma cells PER2 through the regulation of the numerous important downstream tumor-related genes, plays a major role in tumor suppression.
Data suggest that Per2 is not only a tumor suppressor gene but can also be regarded as a regulator of MDM2 (zeige MDM2 Antikörper)-TP53 (zeige TP53 Antikörper) pathway.
the clock gene PER2 polymorphisms account for the physiological variation of melatonin suppression as circadian light sensitivity
This study showed that Lack of Association between Genetic Polymorphism of PER2 gene with Late Onset Depression and Alzheimer's Disease in a Sample of a Brazilian Population
Results show that PER2 expression and stability is regulated by CSNK1D (zeige CSNK1D Antikörper) which can itself be regulated by phosphorylation on its regulatory domain in a site-specific manner.
miR (zeige MLXIP Antikörper)-21 as cardioprotective downstream target of Per2
Per2 is closely and negatively associated with the occurrence and development of ovarian cancer. Per2 expression, and the clinical stage and TNM (zeige ODZ1 Antikörper) development of ovarian cancer were identified to be correlated.
results indicate the involvement of PER2 in the homeostatic process of sleep
Per2 acted here as a liver tumor suppressor from initiation to progression.
Atxn2 (zeige ATXN2 Antikörper)(-/-) mice showed an unstable rhythmicity of locomotor activity, but the level of PER1 (zeige PER1 Antikörper) and PER2 IR in the SCN (zeige SRI Antikörper) did not differ between genotypes.
A knockin mouse expressing a fluorescent fusion of native PER2 protein (PER2::VENUS) for live imaging showed how the mobility and nuclear translocation of PER2 are regulated by casein kinase.
Data indicate that following removal of tetrodotoxin (TTX), the dorsal region attained a stable period after the ventral region and an earlier time of peak PERIOD2 (PER2) expression.
Data show that extracellular luciferin concentration significantly affects the apparent circadian amplitude and phase of PER2::LUC reporter in cultured fibroblasts, but not in suprachiasmatic nucleus (SCN (zeige SRI Antikörper)).
The Per2 function in the bone marrow is required for the regulation of life span in circulating erythrocytes.
these results identify Per2 as a negative regulator of Ly-biased haematopoietic stem cells and immune functions in response to DNA damage and ageing.
beta-amyloid protein (31-35) altered the expression of the Per1 and Per2 in the suprachiasmatic nucleus, hippocampus and heart. These findings provide experimental evidence for circadian rhythm disturbances in patients with Alzheimer's disease.
Circadian PER2 rhythm in the olfactory bulb of freely moving mice is organized by the nucleus circadian pacemaker, and is independent of the circadian behavioral rhythm
Upon inhibition of protein synthesis, D-box mediated gene expression is abolished while the E-box confers light driven activation as observed in the per2 gene.
Opposing effects of circadian clock genes bmal1 (zeige ARNTL Antikörper) and period2 in regulation of VEGF (zeige VEGFA Antikörper)-dependent angiogenesis in developing zebrafish.
light-dependent crosstalk between E- and D-box binding factors is a central determinant of per2 expression.
PER2 regulates the sub-cellular distributions of zCLOCK and zBMAL proteins.
This gene is a member of the Period family of genes and is expressed in a circadian pattern in the suprachiasmatic nucleus, the primary circadian pacemaker in the mammalian brain. Genes in this family encode components of the circadian rhythms of locomotor activity, metabolism, and behavior. Circadian expression in the suprachiasmatic nucleus continues in constant darkness, and a shift in the light/dark cycle evokes a proportional shift of gene expression in the suprachiasmatic nucleus. The specific function of this gene is not yet known.
circadian clock protein PERIOD 2
, period 2
, period circadian protein 2
, period circadian protein homolog 2
, period homolog 2
, period circadian clock 2